✦ LIBER ✦

FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease

✍ Scribed by Lale Kostakoglu; Stanley J. Goldsmith; John P. Leonard; Paul Christos; Richard R. Furman; Tamer Atasever; Angely Chandramouly; Sumeet Verma; Pratichi Kothari; Morton Coleman

Book ID: 102110283
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 168 KB
Volume: 107
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.22276

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FDG-PET after two cycles of chemotherapy

FDG-PET after two cycles of chemotherapy predicts treatment failure and Progression-free survival in Hodgkin’s lymphoma

✍ Carol S. Portlock 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 47 KB

2105 POSTER Positive Predictive Value of

2105 POSTER Positive Predictive Value of PET- CT in Evaluating Post Therapy Residues of Hodgkin Lymphoma and Diffuse Large B Cell Lymphoma

✍ K. Rathnam; T.G. Sagar; S. Cyriac 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Nuclear expression of YB-1 in diffuse la

Nuclear expression of YB-1 in diffuse large B-cell lymphoma: correlation with disease activity and patient outcome

✍ WenLing Xu; LeiLei Zhou; RuJuan Qin; HuaRong Tang; HuiLing Shen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

Prognostic significance of interim 18F-F

Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma

✍ Deok-Hwan Yang; Jung-Joon Min; Ho-Chun Song; Yong Yeon Jeong; Woong-Ki Chung; So 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 554 KB

The number of tumour-infiltrating TIA-1+

The number of tumour-infiltrating TIA-1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B-cell lymphoma

✍ Sverker Hasselblom; Margret Sigurdadottir; Ulrika Hansson; Herman Nilsson-Ehle; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

Infused CD34+ cell dose, but not tumour

Infused CD34+ cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy

✍ A. K. Blystad; J. Delabie; S. Kvaløy; H. Holte; H. Vålerhaugen; I. Ikonomou; G. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB